Search

everythinglearnresearchcommunity

for

Search:↓

Curcuma aeruginosa rhizome extracts show potential as anticancer agents, with varying effectiveness against breast cancer cells.

The methanolic fruit extract of Citrullus colocynthis contains bioactive compounds that may support its use in traditional medicine and drug development.

A new method accurately measures lead levels in hair to assess exposure.

Laser ablation ICP-MS is effective for tracking trace elements in polar bear hair over time.

The study developed methods to measure biomarkers in mice and found differences in hormone levels linked to gut microbiota diversity and stress response.

Researchers developed a precise method to detect illegal hair-growth drugs in dietary supplements.

Certain polyphenols may help treat skin pigmentation disorders.

Systemic corticosteroids might help treat hair loss caused by alemtuzumab in MS patients.

Unripe fruits of three banana species have many health-boosting compounds useful for medicine.

Coconut seed extract may effectively treat scabies in rabbits by killing mites and reducing inflammation.

Two patients developed complete hair loss after Alemtuzumab treatment for MS, with no regrowth after two years.

MS patients often have skin issues, so regular skin checks are important.

Interferon beta treatment in MS patients can cause skin reactions and increased hair loss.

Combining minoxidil with MS injections leads to better hair regrowth in men.

EPDS and MS might share an immune-related cause.

Nail loss may be a side effect of the MS drug teriflunomide.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Taking vitamin D might improve life for MS patients and reduce skin side effects from alemtuzumab treatment.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

The article suggests managing interferon beta therapy side effects in MS with dose adjustments, medications, and patient education.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Teriflunomide often causes mild to moderate hair thinning and loss in MS patients, which usually improves with or without treatment.

PCOS is common among Chinese women of reproductive age and linked to serious metabolic and reproductive issues, especially in obese women.

Hair loss linked to higher heart disease risk in both men and women.

The article concludes that proper injection techniques and patient education can prevent serious skin reactions from multiple sclerosis medications.

Environmental factors can greatly reduce drug levels in hair.

Family members of North Indian women with PCOS have a high rate of metabolic syndrome.

People with early hair loss may have higher insulin levels and a greater chance of developing metabolic syndrome.

Lipid-coated silica nanoparticles penetrate human skin more deeply than bare silica nanoparticles.